NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients

In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kute, Vivek B, Agarwal, Sanjay K, Prakash, Jai, Guleria, Sandeep, Shroff, Sunil, Sharma, Ashish, Varma, Prem, Prasad, Narayan, Sahay, Manisha, Gupta, Subhash, Sudhindran, S, Krishan, Kewal, Ramesh, Vasanthi, Kumar, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240933/
https://www.ncbi.nlm.nih.gov/pubmed/34267426
http://dx.doi.org/10.4103/ijn.IJN_64_21
Descripción
Sumario:In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmission and enhance herd immunity. Immuno-compromised patients should not receive live vaccines as they can cause vaccine-related disease and hence the guidelines suggest that all transplant recipients should receive age-appropriate 'inactivated vaccine' as recommended for general population. Though trials have not been undertaken on transplant recipients, efficacy and safety of COVID-19 vaccine have been scientifically documented for few vaccines among the general population.

Ejemplares similares